Welcome to our dedicated page for Klotho Neurosciences news (Ticker: KLTO), a resource for investors and traders seeking the latest updates and insights on Klotho Neurosciences stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Klotho Neurosciences's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Klotho Neurosciences's position in the market.
Klotho Neurosciences (NASDAQ: KLTO) has announced that Dr. Robert Langer, co-founder of Moderna, has joined its Scientific Advisory Board. Dr. Langer, a renowned biotech leader and MIT professor, will contribute his expertise in neuroscience and therapeutics development. Klotho Neurosciences is developing novel therapies for neurodegenerative diseases, leveraging research on the Klotho protein, an anti-aging factor with neuroprotective potential.
The company's platform focuses on the secreted form of Klotho, s-KL, which is patented in several countries. Dr. Joseph Sinkule, Chairman and CEO of Klotho Neurosciences, expressed enthusiasm about Dr. Langer's vast experience in translational medicine and therapeutic innovation. Dr. Langer will provide guidance on the scientific and clinical development of the company's product candidates, supporting efforts to address major unmet medical needs in neurodegenerative disorders such as ALS, Alzheimer's, and Parkinson's disease.
FAQ
What is the current stock price of Klotho Neurosciences (KLTO)?
What is the market cap of Klotho Neurosciences (KLTO)?
